These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1100962)

  • 1. Preliminary report of a drug trial conducted at Leprosy Relief Rural Centre, Chettipatty, South India.
    Vomstein E
    Lepr Rev; 1975 Jun; 46(2 Suppl):207-13. PubMed ID: 1100962
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to 'Elimination of leprosy in India: An analysis'.
    Kumar B
    Indian J Dermatol Venereol Leprol; 2018; 84(4):443-444. PubMed ID: 29893302
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
    Krenzien HN
    Lepr Rev; 1975 Jun; 46(2 Suppl):189-98. PubMed ID: 1100960
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.
    Aschhoff M
    Lepr Rev; 1975 Jun; 46(2 Suppl):173-8. PubMed ID: 1165697
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined therapy in leprosy.
    Gatti JC
    Lepr Rev; 1975 Jun; 46(2 Suppl):155-60. PubMed ID: 1100955
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
    Mysore V; al-Suwaid AR
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):159-61. PubMed ID: 10472369
    [No Abstract]   [Full Text] [Related]  

  • 7. Report of combined therapy in leprosy with rifampicin and isoprodian conducted at the Bisidimo-center, Ethiopia.
    Rohde R
    Lepr Rev; 1975 Jun; 46(2 Suppl):199-205. PubMed ID: 1100961
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifampicin and isoprodian in combination in the treatment of leprosy.
    Depasquale G
    Lepr Rev; 1975 Jun; 46(2 Suppl):179-80. PubMed ID: 1100958
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of leprosy with rifampicin and isoprodian (L73A).
    Terencio de las Aguas J
    Lepr Rev; 1975 Jun; 46(2 Suppl):165-8. PubMed ID: 1100956
    [No Abstract]   [Full Text] [Related]  

  • 10. Care after cure in leprosy.
    John TJ; Muliyil J
    Lancet; 2001 Jan; 357(9252):313. PubMed ID: 11214161
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
    Innami S; Leguizamón OR; Alvarenga AE
    Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
    [No Abstract]   [Full Text] [Related]  

  • 12. [How should leprosy be treated?].
    Mahé A
    Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
    [No Abstract]   [Full Text] [Related]  

  • 13. Informal consultation on rifampicin resistance in leprosy.
    Lepr Rev; 2007 Sep; 78(3):295-305. PubMed ID: 18035782
    [No Abstract]   [Full Text] [Related]  

  • 14. Do complications occur under multi-drug therapy?
    Palande DD
    Indian J Lepr; 1987; 59(4):369-72. PubMed ID: 3451922
    [No Abstract]   [Full Text] [Related]  

  • 15. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 16. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks.
    Ji B
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary experience with combined therapy using rifampicin and isoprodian (L73A).
    Freerksen E
    Lepr Rev; 1975 Jun; 46(2 Suppl):161-3. PubMed ID: 1165695
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of sulphone resistant leprosy--a review of sixty one cases.
    Seshadri PS; Ravi NT
    Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of an immunomodulant, isoprinosine, in multibacillary leprosy. Preliminary study].
    Saint-André P; Ferracci C; Ridel PR; Baquillon C; Boucher P
    Acta Leprol; 1982; (86-87):113-29. PubMed ID: 6183917
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifampicin: the investigation of a bactericidal antileprosy drug.
    Rees RJ
    Lepr Rev; 1975 Jun; 46(2 Suppl):121-4. PubMed ID: 1100951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.